MyFinsight
Home
About
Contact
tnxp: the income statement
Download
Download image
Net loss available
to common...
-$32,010K
(-125.22%↓ Y/Y)
Interest income
$1,231K
Grant income
$982K
(-41.13%↓ Y/Y)
Tosymra
$708K
(110.09%↑ Y/Y)
Zembrace Symtouch
$2,582K
Other expense, net
-$1,156K
(-253.52%↓ Y/Y)
Operating loss
-$33,067K
(-112.59%↓ Y/Y)
Product revenue, net
$3,290K
(16.58%↑ Y/Y)
Costs and expenses
$36,357K
(97.85%↑ Y/Y)
Selling, general and
administrative
$25,701K
(233.48%↑ Y/Y)
Research and development
$9,289K
(1.92%↑ Y/Y)
Cost of revenue
$1,367K
(-12.09%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Tonix Pharmaceuticals Holding Corp. (TNXP)
Tonix Pharmaceuticals Holding Corp. (TNXP)